Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This 10-day sequential therapy is a specific treatment regimen developed and evaluated at Kaohsiung Veterans General Hospital for the eradication of *Helicobacter pylori* infection. The regimen is structured into two distinct phases: the first 5 days involve the administration of a proton pump inhibitor (pantoprazole 40 mg twice daily) and amoxicillin (1 g twice daily); the subsequent 5 days consist of the proton pump inhibitor (pantoprazole 40 mg twice daily) combined with clarithromycin (500 mg twice daily) and metronidazole (500 mg twice daily). This sequential approach is designed to improve eradication rates by first reducing the bacterial load and weakening the cell wall with amoxicillin, thereby enhancing the efficacy of clarithromycin and metronidazole in the second phase, particularly in populations with high antibiotic resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pantoprazole + amoxicillin + clarithromycin + metronidazole.